NEW YORK (360Dx) – Barclays today initiated coverage of Abbott Laboratories with an Overweight rating for its stock and a target price of $80 per share. It also initiated coverage of Becton Dickinson with an Equal Weight rating and stock price target of $278.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.